Back to Search
Start Over
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System.
- Source :
- Drug Safety; Mar2023, Vol. 46 Issue 3, p283-295, 13p
- Publication Year :
- 2023
-
Abstract
- Introduction: Deliberate self-poisoning (DSP) using drugs is the preferred method of suicide at a global level. Its investigation is hampered by limited sample sizes and data reliability. We investigate the role of the US FDA Adverse Event Reporting System (FAERS), a consolidated pharmacovigilance database, in outlining DSP habits and toxidromes. Methods: We retrieved cases of 'intentional overdose' and 'poisoning deliberate' from the FAERS (January 2004–December 2021). Using descriptive and disproportionality analyses, we estimated temporal trends, potential risk factors, toxidromes, case-fatality rates and lethal doses (LDs) for the most frequently reported drugs. Results: We retrieved 42,103 DSP cases (17% fatal). Most cases were submitted in winter. Reports of DSP involved younger people, psychiatric conditions, and alcohol use, compared with non-DSP, and fatality was higher in men and older patients. Suspected drugs were mainly antidepressants, analgesics, and antipsychotics. Multiple drug intake was recorded in more than 50% of the reports, especially analgesics, psychotropics, and cardiovascular agents. The most frequently reported drugs were paracetamol, promethazine, amlodipine, quetiapine, and metformin. We estimated LD25 for paracetamol (150 g). Conclusion: Worldwide coverage of the FAERS complements existing knowledge about DSP and may drive tailored prevention measures to timely address the DSP phenomenon and prevent intentional suicides. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01145916
- Volume :
- 46
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Drug Safety
- Publication Type :
- Academic Journal
- Accession number :
- 162260771
- Full Text :
- https://doi.org/10.1007/s40264-022-01269-x